Giuliano La Fratta
Director of Finance/CFO at AETERNA ZENTARIS INC.
Net worth: - $ as of 2024-03-30
Profile
Giuliano La Fratta is currently the Chief Financial Officer & Senior Vice President at Æterna Zentaris, Inc. Prior to this, he was the Vice President-Finance at CellCarta Biosciences, Inc. He obtained his undergraduate degree from Concordia University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
AETERNA ZENTARIS INC.
-.--% | 2024-01-11 | 0 ( -.--% ) | - $ | 2024-03-30 |
Giuliano La Fratta active positions
| Companies | Position | Start |
|---|---|---|
| AETERNA ZENTARIS INC. | Director of Finance/CFO | 2022-01-23 |
Former positions of Giuliano La Fratta
| Companies | Position | End |
|---|---|---|
CellCarta Biosciences, Inc.
 CellCarta Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services CellCarta Biosciences, Inc. develops proteomics and immune monitoring services. The firm offers integrated platforms in proteomics and immune monitoring services to the pharmaceutical and biotechnology industry. Its services include biomarker discovery, cell engine software, cellular enumeration, clinical laboratory services, functional profiling, host cell proteins detection, phenotyping characterization and receptor occupancy. The company was founded by Martin LeBlanc in 2000 and is headquartered in Montréal, Canada. | Corporate Officer/Principal | - |
Training of Giuliano La Fratta
| Concordia University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| AETERNA ZENTARIS INC. | Health Technology |
| Private companies | 1 |
|---|---|
CellCarta Biosciences, Inc.
CellCarta Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services CellCarta Biosciences, Inc. develops proteomics and immune monitoring services. The firm offers integrated platforms in proteomics and immune monitoring services to the pharmaceutical and biotechnology industry. Its services include biomarker discovery, cell engine software, cellular enumeration, clinical laboratory services, functional profiling, host cell proteins detection, phenotyping characterization and receptor occupancy. The company was founded by Martin LeBlanc in 2000 and is headquartered in Montréal, Canada. | Commercial Services |
- Stock Market
- Insiders
- Giuliano La Fratta
